Influenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts
- PMID: 22558251
- PMCID: PMC3340400
- DOI: 10.1371/journal.pone.0035876
Influenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts
Abstract
The type II transmembrane serine proteases TMPRSS2 and HAT activate influenza viruses and the SARS-coronavirus (TMPRSS2) in cell culture and may play an important role in viral spread and pathogenesis in the infected host. However, it is at present largely unclear to what extent these proteases are expressed in viral target cells in human tissues. Here, we show that both HAT and TMPRSS2 are coexpressed with 2,6-linked sialic acids, the major receptor determinant of human influenza viruses, throughout the human respiratory tract. Similarly, coexpression of ACE2, the SARS-coronavirus receptor, and TMPRSS2 was frequently found in the upper and lower aerodigestive tract, with the exception of the vocal folds, epiglottis and trachea. Finally, activation of influenza virus was conserved between human, avian and porcine TMPRSS2, suggesting that this protease might activate influenza virus in reservoir-, intermediate- and human hosts. In sum, our results show that TMPRSS2 and HAT are expressed by important influenza and SARS-coronavirus target cells and could thus support viral spread in the human host.
Conflict of interest statement
Figures
Similar articles
-
TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein.J Virol. 2014 Jan;88(2):1293-307. doi: 10.1128/JVI.02202-13. Epub 2013 Nov 13. J Virol. 2014. PMID: 24227843 Free PMC article.
-
Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease.J Virol. 2011 Dec;85(24):13363-72. doi: 10.1128/JVI.05300-11. Epub 2011 Oct 12. J Virol. 2011. PMID: 21994442 Free PMC article.
-
Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2.J Virol. 2010 Dec;84(24):12658-64. doi: 10.1128/JVI.01542-10. Epub 2010 Oct 6. J Virol. 2010. PMID: 20926566 Free PMC article.
-
Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research.Antiviral Res. 2013 Dec;100(3):605-14. doi: 10.1016/j.antiviral.2013.09.028. Epub 2013 Oct 8. Antiviral Res. 2013. PMID: 24121034 Free PMC article. Review.
-
ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19.Biomed Pharmacother. 2020 Nov;131:110678. doi: 10.1016/j.biopha.2020.110678. Epub 2020 Aug 24. Biomed Pharmacother. 2020. PMID: 32861070 Free PMC article. Review.
Cited by
-
Computationally designed Spike antigens induce neutralising responses against the breadth of SARS-COV-2 variants.NPJ Vaccines. 2024 Sep 9;9(1):164. doi: 10.1038/s41541-024-00950-9. NPJ Vaccines. 2024. PMID: 39251608 Free PMC article.
-
Immediate myeloid depot for SARS-CoV-2 in the human lung.Sci Adv. 2024 Aug 2;10(31):eadm8836. doi: 10.1126/sciadv.adm8836. Epub 2024 Jul 31. Sci Adv. 2024. PMID: 39083602 Free PMC article.
-
Vaccine targeting to mucosal lymphoid tissues promotes humoral immunity in the gastrointestinal tract.Sci Adv. 2024 May 31;10(22):eadn7786. doi: 10.1126/sciadv.adn7786. Epub 2024 May 29. Sci Adv. 2024. PMID: 38809992 Free PMC article.
-
COVID-19 susceptibility: potential of ACE2 polymorphisms.Egypt J Med Hum Genet. 2020;21(1):54. doi: 10.1186/s43042-020-00099-9. Epub 2020 Sep 21. Egypt J Med Hum Genet. 2020. PMID: 38624559 Free PMC article. Review.
-
The Influenza A Virus Replication Cycle: A Comprehensive Review.Viruses. 2024 Feb 19;16(2):316. doi: 10.3390/v16020316. Viruses. 2024. PMID: 38400091 Free PMC article. Review.
References
-
- Skowronski DM, Astell C, Brunham RC, Low DE, Petric M, et al. Severe acute respiratory syndrome (SARS): a year in review. Annu Rev Med. 2005;56:357–381. - PubMed
-
- Parrish CR, Kawaoka Y. The origins of new pandemic viruses: the acquisition of new host ranges by canine parvovirus and influenza A viruses. Annu Rev Microbiol. 2005;59:553–586. - PubMed
-
- Wang W, Butler EN, Veguilla V, Vassell R, Thomas JT, et al. Establishment of retroviral pseudotypes with influenza hemagglutinins from H1, H3, and H5 subtypes for sensitive and specific detection of neutralizing antibodies. J Virol Methods. 2008;153:111–119. - PubMed
-
- Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426:450–454. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous